Brief: Probiotec Expects FY22 Underlying EBITDA Of A$32 Mln-A$33 Mln
Feb 25 (Reuters) - Probiotec Ltd PBP.AX :
* FY22 GUIDANCE UPDATE
* SEES FY22 REVENUE OF BETWEEN A$175 MILLION AND A$180
MILLION
* SEES FY22 UNDERLYING EBITDA OF BETWEEN A$32 MILLION AND
A$33
MILLION
Source text for Eikon: ID:nASX7Gv0Yb
Further company coverage: PBP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Probiotec
See all newsBrief: ASX Says Probiotec Limited Will Be Removed From The Official List At Close Of Trading On 19 June
Australia's Probiotec hits 4-month high on nod for Pyridam buyout
Brief: Probiotec Says FIRB Condition Satisfied For Proposed Scheme
Australia's Probiotec hits record high on takeover offer
Brief: Probiotec Remains Confident Of Achieving Growth In Sales And Earnings For FY24